New insights into the roles for DYRK family in mammalian development and congenital diseases

Saishu Yoshida; Kiyotsugu Yoshida

doi:10.1016/j.gendis.2021.12.004

您当前的位置：

首页 >

文章列表页 >

New insights into the roles for DYRK family in mammalian development and congenital diseases

Review article | 更新时间：2023-08-29

- New insights into the roles for DYRK family in mammalian development and congenital diseases
- New insights into the roles for DYRK family in mammalian development and congenital diseases
- Genes & Diseases 2023年10卷第3期
- 作者机构：
  
  Department of Biochemistry, The Jikei University School of Medicine, Minato-, Tokyo 61,ku,Japan,105 84
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.12.004
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-5-1，
扫描看全文
New insights into the roles for DYRK family in mammalian development and congenital diseases[J]. Genes & Diseases, 2023,10(3).

Saishu Yoshida, Kiyotsugu Yoshida. New insights into the roles for DYRK family in mammalian development and congenital diseases[J]. Genes & Diseases, 2023,10(3).
New insights into the roles for DYRK family in mammalian development and congenital diseases[J]. Genes & Diseases, 2023,10(3). DOI： 10.1016/j.gendis.2021.12.004.

Saishu Yoshida, Kiyotsugu Yoshida. New insights into the roles for DYRK family in mammalian development and congenital diseases[J]. Genes & Diseases, 2023,10(3). DOI： 10.1016/j.gendis.2021.12.004.

摘要

Abstract

The dual-specificity tyrosine-regulated kinase (DYRK) family is evolutionarily conserved from invertebrate to mammals. DYRKs regulate cell proliferation

apoptosis

survival

and differentiation by modifying the protein activation state

cellular localization

and turnover. In contrast to several studies in cellular models

the available evidence regarding the

in vivo

roles of DYRKs in mammalian development is limited. This review summarizes the

in vivo

studies on

Dyrks

which provide insight into their roles in mammalian tissue development and congenital diseases.

In vivo

evidence obtained using knockout and genetically modified animals helps to understand and develop novel clinical therapies and drug for human congenital diseases

such as Down syndrome and neuronal disorders (associated with DYRK1A) and skeletal ciliopathies (associated with DYRK2).

关键词

Keywords

CiliopathiesDevelopmentDown syndromeDYRKsEmbryogenesis

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities

Coactivator-associated arginine methyltransferase 1: A versatile player in cell differentiation and development

MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma

SATB2: A versatile transcriptional regulator of craniofacial and skeleton development, neurogenesis and tumorigenesis, and its applications in regenerative medicine

Calcineurin in development and disease